Skip to main content
. 2023 May 18;18(5):1517–1547. doi: 10.1007/s11764-023-01395-0

Table 2.

Summary of exploratory findings: The effect of upper-body morbidity on quality of life according to questionnaire

Questionnaire subscales
Questionnaire Negative effect due to UBM No effect due to UBM
SF-36 Physical wellbeing
Physical role functioning
Emotional role functioning
Energy/fatigue
Mental health
Social function
Bodily pain
General health
SF-12 Physical component score
Mental component score
EORTC QLQ-C30 Global health status Emotional functioning
Physical functioning Cognitive functioning
Role functioning
Social functioning
EORTC QLQ-BR23 Breast symptoms Body image
Sexual function
Sexual enjoyment
Arm symptoms
Future perspectives
FACT-B + 4 Total FACT-B Social/family wellbeing
Total FACT-B + 4
Physical wellbeing
Emotional wellbeing
Functional wellbeing
Breast cancer subscale
Arm symptom subscale
WHOQOL-BREF Physical health Environmental health
Social relationships General health

World Health Organisation Quality of Life questionnaire, Brief (WHOQOL-BREF); European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire, Core 30 (EORTC QLQ-C30); European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire, Breast cancer module (EORTC QLQ-BR23) Functional Assessment of Cancer Therapy, Breast (with arm symptoms subscale) (FACT-B + 4); Short form 12 (SF-12); Short form 36 (SF-36)

No applicable subscales

Exceeds MCID/MID for questionnaire subscale